Want to see CPMD full AI Analyst Report?
Cannapharmarx (CPMD) Financial Statements
Cannapharmarx Financial Overview
Cannapharmarx's market cap is currently $1.42M. The company's EPS TTM is $-0.02; its P/E ratio is -0.12; Cannapharmarx has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.36M | $ 820.14K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -2.08M | $ -2.94M | $ -65.56K | $ -295.00K | $ -14.36K |
| Operating Income | $ -3.35M | $ -3.61M | $ -1.58M | $ -5.21M | $ -2.99M |
| EBITDA | $ -3.25M | $ -7.53M | $ -1.45M | $ -4.91M | $ -2.61M |
| Net Income | $ -11.13M | $ -9.91M | $ 3.69M | $ -8.53M | $ -8.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.80K | $ 2.16K | $ 650.00 | $ 2.32K | $ 27.77K |
| Total Assets | $ 7.02M | $ 10.84M | $ 11.75M | $ 5.41M | $ 114.33K |
| Total Debt | $ 20.65M | $ 14.06M | $ 12.94M | $ 14.52M | $ 9.02M |
| Net Debt | $ 20.65M | $ 14.06M | $ 12.93M | $ 14.52M | $ 8.99M |
| Total Liabilities | $ 37.17M | $ 30.65M | $ 23.90M | $ 22.76M | $ 13.04M |
| Stockholders' Equity | $ -30.15M | $ -19.81M | $ -12.15M | $ -17.34M | $ -12.93M |
| Cash Flow | |||||
| Free Cash Flow | $ -794.62K | $ -1.70M | $ -2.36M | $ -1.56M | $ -2.42M |
| Operating Cash Flow | $ -789.10K | $ -1.70M | $ -2.27M | $ -1.45M | $ -2.41M |
| Investing Cash Flow | $ -5.52K | $ 0.00 | $ -80.63K | $ -116.00K | $ 493.62K |
| Financing Cash Flow | $ 794.27K | $ 1.70M | $ 2.35M | $ 1.40M | $ 1.30M |
Currency in USD
